This binding promotes the ubiquitin-mediated degradation of CTH, thereby increasing the intra- and extracellular levels of Gly/Ser/Thr and inducing the formation of an abnormal tumor metabolic microenvironment that ultimately renders lung cancer cells insensitive to radiotherapy. The gene discussed is CTH; the disease is lung cancer.